Acute Effects of Resistance Exercise-Based PAPE in Adolescent Basketball Players (PAPE)

November 19, 2026 updated by: Mertkan Öncü, Uludag University

Acute Effects of Resistance Exercise-Based PAPE on Basketball-Specific Cognitive-Motor Dual-Task Performance in Adolescent Basketball Players: A Randomized Crossover Study

This study evaluates the acute effects of resistance exercise-based post-activation performance enhancement (PAPE) on basketball-specific cognitive-motor dual-task performance in male adolescent basketball players. Twenty-one basketball players aged 15 to 17 years complete three experimental conditions in a randomized crossover design: a standardized basketball warm-up, 5 repetitions of the back squat at 80% of individual one-repetition maximum (1RM), and 5 repetitions of the deadlift at 80% of individual 1RM. Each participant completes all three conditions with 48 hours between experimental sessions. Basketball-specific cognitive-motor dual-task performance is assessed before and after each condition using a task adapted from the NBA Draft Combine dribbling test that incorporates simultaneous motor responses to visual stimuli. The primary purpose is to compare the acute changes in performance following the two resistance exercise-based PAPE conditions with those following the standardized basketball warm-up.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

21

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Bursa
      • Bursa, Bursa, Turkey (Türkiye), 16000
        • Bursa Uludag University, Faculty of Sport Sciences

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 17 years (Child)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Male basketball players aged 16-17 years.
  • At least two years of regular basketball training experience.
  • Ability to safely perform the back squat and deadlift exercises and complete the basketball-specific cognitive-motor dual-task test.
  • Written informed consent from a parent or legal guardian and assent from the participant.
  • No serious musculoskeletal injury affecting sports performance within the previous six months.

Exclusion Criteria:

  • Any musculoskeletal condition that prevented safe completion of the resistance exercise or basketball-specific testing procedures.
  • Inability to complete any of the experimental conditions or required performance assessments.
  • Failure to comply with the pre-session requirements, including avoidance of strenuous physical activity and caffeine consumption.
  • Withdrawal of participant assent or parental/legal guardian consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Standardized Basketball Warm-Up

Participants completed a standardized basketball warm-up condition. Basketball-specific cognitive-motor dual-task performance was assessed before the conditioning activity and again after the condition. This condition served as the active comparator for the two resistance exercise-based PAPE conditions.

Participants performed a standardized basketball warm-up as the active comparator condition. Basketball-specific cognitive-motor dual-task performance was assessed before the warm-up and again after completion of the condition.

Experimental: Back Squat PAPE

Participants completed 5 repetitions of the back squat exercise at 80% of their individual one-repetition maximum (1RM) as a resistance exercise-based PAPE condition. Basketball-specific cognitive-motor dual-task performance was assessed before the conditioning activity and again after a 3-5-minute recovery period.

Participants performed 5 repetitions of the back squat exercise at 80% of their individual one-repetition maximum (1RM) as a resistance exercise-based PAPE conditioning activity. Following the conditioning activity, participants completed a 3-5-minute recovery period before post-intervention assessment of basketball-specific cognitive-motor dual-task performance.

Experimental: Deadlift PAPE

Participants completed 5 repetitions of the deadlift exercise at 80% of their individual one-repetition maximum (1RM) as a resistance exercise-based PAPE condition. Basketball-specific cognitive-motor dual-task performance was assessed before the conditioning activity and again after a 3-5-minute recovery period.

Participants performed 5 repetitions of the deadlift exercise at 80% of their individual one-repetition maximum (1RM) as a resistance exercise-based PAPE conditioning activity. Following the conditioning activity, participants completed a 3-5-minute recovery period before post-intervention assessment of basketball-specific cognitive-motor dual-task performance.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Basketball-Specific Cognitive-Motor Dual-Task Performance
Time Frame: Immediately before and 3-5 minutes after each experimental condition

Performance was assessed using a cognitive-motor dual-task adapted from the NBA Draft Combine dribbling test. Participants completed the basketball-specific dribbling course while simultaneously responding to visual stimuli with corresponding motor responses. Performance was recorded as task completion time in seconds using an electronic timing system. A shorter completion time indicated better performance.

Immediately before and 3-5 minutes after each experimental condition

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 26, 2026

Primary Completion (Actual)

October 12, 2026

Study Completion (Actual)

October 12, 2026

Study Registration Dates

First Submitted

September 25, 2026

First Submitted That Met QC Criteria

September 25, 2026

First Posted (Actual)

October 1, 2026

Study Record Updates

Last Update Posted (Actual)

November 20, 2026

Last Update Submitted That Met QC Criteria

November 19, 2026

Last Verified

September 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 2026/276/10-10

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Anonymized individual participant data underlying the results reported in the publication may be made available to qualified researchers upon reasonable request to the corresponding author, subject to applicable institutional and ethical restrictions.

IPD Sharing Time Frame

Anonymized IPD may be made available following publication of the study results. No predetermined end date is specified; availability will be subject to applicable institutional and ethical requirements.

IPD Sharing Access Criteria

Anonymized IPD may be provided to qualified researchers upon reasonable request to the corresponding author. Requests should include a scientifically appropriate purpose for the proposed use of the data. Access will be considered in accordance with applicable institutional and ethical requirements.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.